GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Human Genome Sciences, Inc. (HGSI) [hlAlert]

Rating:
Sell HGSI
up 5.55 %

Human Genome Sciences, Inc. (HGSI) downgraded to Sell with price target $1.50 by ThinkEquity

Posted on: Tuesday,  Jan 27, 2009  8:25 AM ET by ThinkEquity

ThinkEquity rated Sell Human Genome Sciences, Inc. (NASDAQ: HGSI) on 01/27/2009, when the stock price was $2.09. Since then, Human Genome
Sciences, Inc. has lost 5.26% of its value until ThinkEquity rated HGSI Accumulate on 02/27/2009, when the price was $1.98.
If you would have followed this ThinkEquity's recommendation on HGSI, you would have gained 5.55% of your investment in 31 days.

Human Genome Sciences is a biopharmaceutical company with a pipeline of novel compounds in clinical development, including drugs to treat such diseases as hepatitis C, lupus, anthrax disease, cancer, rheumatoid arthritis and HIV/AIDS. Additional products are in clinical development by companies with which we are collaborating. Its mission is to discover, develop, manufacture and market innovative drugs that serve patients with unmet medical needs, with a primary focus on protein and antibody products.

Research is at the core of everything we do at ThinkEquity, and we're passionate about it. Employing a disciplined and rigorous process, we scrutinize the spectrum of forces at play in the growth sectors we cover. Starting with a top down analysis, we look closely at the megatrends and industry drivers that create opportunities for innovative companies. We then allocate our resources based on a long-range research roadmap that leads to deep domain expertise and a close working knowledge of the technologies, products, services and people that populate the growth sector landscape. In short, the sum result of the ThinkEquity research process is to identify and affiliate ourselves with the fastest growing private and public companies within our domain verticals.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/4/2009 8:25 AM Buy
None
14.62 26.00
as of 12/31/2009
1 Week down  -20.14 %
1 Month down  -11.68 %
3 Months up  30.55 %
1 YTD up  73.31 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/21/2009 8:25 AM Buy
None
12.75 14.00
2/27/2009 8:25 AM Buy
None
1.98
1/27/2009 8:25 AM Sell
None
2.09 1.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy